::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

PHARMACOTHERAPEUTIC ANALYSIS OF TUBERCULOSIS

AUTHORS:

Muhammad Nabeel,* Ali Raza, Syed Arsalan Haider, Muhammad Athar Adil, Sibgha Munir

ABSTRACT:

Tuberculosis is an airborne disease caused by the bacterium Mycobacterium tuberculosis. M. tuberculosis and seven very closely related mycobacterial species (M. bovis, M. africanum, M. microti, M. caprae, M. pinnipedii, M. canetti and M. mungi) together comprise what is known as the M. tuberculosis complex. Most, but not all, of these species have been found to cause disease in humans. The case study has been designed to report pulmonary tuberculosis in a patient of 45 years age admitted in the DHQ Sialkot, who is recently diagnosed as having the disease but the symptoms and seriousness of disease was at its peak at the time of diagnosis. Complete history of the patient is taken along with his past medical history by direct interview of the patient. His chest X-ray as well as sputum AFB detection reveals the presence of disease. Patient was hospitalized until the confirmation of diagnosis and was discharged with the instruction of anti-tuberculosis drugs therapy. After studying and analyzing tuberculosis I concluded that, the treatment prescribed by physician is rational and true. Keywords: Multi-drug resistance tuberculosis (MDRTB), Tuberculosis, Rifampicin, Pyrazinamide